BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12094227)

  • 1. Apoptosis as a therapeutic tool in rheumatoid arthritis.
    Pope RM
    Nat Rev Immunol; 2002 Jul; 2(7):527-35. PubMed ID: 12094227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis in rheumatoid arthritis: friend or foe.
    Liu H; Pope RM
    Rheum Dis Clin North Am; 2004 Aug; 30(3):603-25, x. PubMed ID: 15261344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
    Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
    Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SCID mouse model: novel therapeutic targets - lessons from gene transfer.
    Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S
    Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.
    Schedel J; Gay RE; Kuenzler P; Seemayer C; Simmen B; Michel BA; Gay S
    Arthritis Rheum; 2002 Jun; 46(6):1512-8. PubMed ID: 12115181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death in rheumatoid arthritis.
    Korb A; Pavenstädt H; Pap T
    Apoptosis; 2009 Apr; 14(4):447-54. PubMed ID: 19199037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent topics in histopathology associated with joint destruction in rheumatoid arthritis].
    Sawai T; Uzuki M
    Clin Calcium; 2009 Mar; 19(3):325-38. PubMed ID: 19252242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective elimination of synovial inflammatory macrophages in rheumatoid arthritis by an Fcgamma receptor I-directed immunotoxin.
    van Roon JA; van Vuuren AJ; Wijngaarden S; Jacobs KM; Bijlsma JW; Lafeber FP; Thepen T; van de Winkel JG
    Arthritis Rheum; 2003 May; 48(5):1229-38. PubMed ID: 12746896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M; Brentano F; Rethage J; Wagner U; Hantzschel H; Gay RE; Gay S; Kyburz D
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
    Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
    Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors underlying chronic inflammation in rheumatoid arthritis.
    Wong SH; Lord JM
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):379-88. PubMed ID: 15577739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
    Bai S; Liu H; Chen KH; Eksarko P; Perlman H; Moore TL; Pope RM
    Arthritis Rheum; 2004 Dec; 50(12):3844-55. PubMed ID: 15593196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is early rheumatoid arthritis the same disease process as late rheumatoid arthritis?
    Tak PP
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):17-26. PubMed ID: 11358412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histopathological features of joint destruction in rheumatoid arthritis (RA)].
    Uzuki M; Sawai T; Sasaki Y
    Clin Calcium; 2007 Apr; 17(4):474-83. PubMed ID: 17404475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative histopathological analysis between tenosynovitis and joint synovitis in rheumatoid arthritis.
    Kaibara N; Yamada H; Shuto T; Nakashima Y; Okazaki K; Miyahara H; Esaki Y; Hirata G; Iwamoto Y
    Histopathology; 2008 Jun; 52(7):856-64. PubMed ID: 18462359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for rheumatoid arthritis.
    Burstein H
    Curr Opin Mol Ther; 2001 Aug; 3(4):362-74. PubMed ID: 11525560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts.
    Huber LC; Künzler P; Boyce SH; Michel BA; Gay RE; Ink BS; Gay S
    Ann Rheum Dis; 2008 Mar; 67(3):389-94. PubMed ID: 17660218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
    Yamaguchi Y; Yamamoto K
    Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.